. . . . . . . . . . . . "[Taken together, these results suggest that downregulation of activin A and Smad3, both members of the TGF-I2 pathway, may offer a mechanistic explanation for the inhibitory effect of a high-dose of genistein on UtLM cells, and might be potential therapeutic targets for treatment of clinical cases of uterine leiomyomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2015-02-21"^^ . . "Gene-disease associations manually curated."@en . "DisGeNET evidence - CURATED"@en . "2015-08-25T14:37:57+02:00"^^ . . . . . . . . . . . "v3.0.0.0" . "v3.0.0" .